Asthma in children
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: -Patients who were prescribed one or more times an ICS in the last year. -Patients who were prescribed 2 or more times a prescription of salbutamol or terbutaline in the last year. -Children with only one prescription of salbutamol or terbutaline in the last year and a registered ICPC-code for asthma (R96).
Exclusion criteria
Exclusion criteria: -Children receiving asthma treatment from secondary care. -Children who are not able to perform lung function tests. -Children with other major chronic diseases (children with atopic conditions such as eczema or allergies are not excluded, since this is a prevalent co-morbidity co-morbidity) -Children whose parents are unable to understand verbal Dutch instructions or written Dutch questionnaires. -Children who did not use inhaled asthma medication for at least 6 weeks in the previous year.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The main study parameter is the overall asthma control in 18 months measured by the Childhood Asthma Control Test (C-ACT) | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. C-ACT outcomes during follow-up at 3, 6, 12 and 18 months. 2. Frequency and severity of exacerbations 3. Cost-effectiveness 4. Quality of life assessed by the Standardised Paediatric Asthma Quality of Life Questionnaire (PAQLQ(S)) 5. Patient/parent/nurse/GP satisfaction with delivered care 6. Spirometry: FEV1, Forced Expiratory Flow 75 (FEF 75) and reversibility | — |